{"id":11319,"date":"2025-07-27T00:57:43","date_gmt":"2025-07-26T22:57:43","guid":{"rendered":"https:\/\/valintermed.com\/?p=11319"},"modified":"2025-07-27T00:57:43","modified_gmt":"2025-07-26T22:57:43","slug":"bolezn-nakopleniya-glikogena-tip-7","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/glycogen-storage-disease-type-7\/","title":{"rendered":"Glycogen storage disease type 7"},"content":{"rendered":"
<\/div>\n

Glycogen storage disease type 7, also known as phospholirosine gene mutation, is a rare hereditary disease that belongs to the group of glycogenoses. The main pathogenesis of the disease is a deficiency of the phospholirosine enzyme, which leads to the accumulation of glycogen in the muscles and metabolic disorders. The main clinical manifestations are associated with myopathy, which is identified mainly in children and adolescents. Symptoms include muscle weakness, fatigue, and cramps, which ultimately limit the physical activity and quality of life of patients. Another important aspect is the possibility of serious complications, including cardiovascular disorders.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n